SCHEMBL22456955

SCHEMBL22456955

CP(C)(=O)c1ccc2ccc(-c3ccc4c5c6ccccc6c6ccccc6c5c5nc6ccccc6n5c4c3)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.37
HPGD P15428 8/20 0.37
KDM4E B2RXH2 8/20 0.37
KMT2A Q03164 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 5/20 0.35
POLB P06746 4/20 0.35
HSD17B10 Q99714 3/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.35
MEN1 O00255 3/20 0.33
CAMKK1 Q8N5S9 2/20 0.33
CAMKK2 Q96RR4 2/20 0.33
BCL2 P10415 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
PIM3 Q86V86 1/20 0.33
DYRK2 Q92630 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22456447 0.92 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456899 0.91 ALDH1A1 (0.36) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456900 0.89 BCL2 (0.39) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22457010 0.88 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456748 0.86 KDM4E (0.40) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456898 0.83 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22457014 0.83 HPGD (0.41) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456456 0.82 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456496 0.82 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL22456742 0.82 TUBB4A (0.36) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200303661-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2020-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200303661-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME NR2E3, NR2E1, NOX1 ALDH1A1 2038/4885HPGD 4184/4885KDM4E 2372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.